Sang Ryong Kim
Overview
Explore the profile of Sang Ryong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Park J, Eo H, Lee G, Park S, Shin M, et al.
Acta Pharmacol Sin
. 2025 Mar;
PMID: 40033054
Cerebellar ataxia (CA) is characterized by impaired balance and coordination due to the loss of cerebellar neurons caused by various factors, and effective treatments are currently lacking. Recently, we observed...
2.
Kim Y, Park S, Kim H, Kim S, Jung U
Nutrients
. 2025 Feb;
17(3).
PMID: 39940273
Background/objectives: This research investigated the effects of myricitrin on hypercholesterolemia and non-alcoholic fatty liver disease (NAFLD) in mice given a high-cholesterol diet (HCD). Methods: C57BL/6J mice were maintained for 20...
3.
Kim S, Jung U, Kim S
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860392
The blood-brain barrier (BBB) is a crucial structure that maintains brain homeostasis by regulating the entry of molecules and cells from the bloodstream into the central nervous system (CNS). Neurodegenerative...
4.
Kim S, Jung U, Kim S
Antioxidants (Basel)
. 2025 Jan;
13(12.
PMID: 39765790
Upregulation of reactive oxygen species (ROS) levels is a principal feature observed in the brains of neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD). In these diseases,...
5.
Eo H, Kim S, Jung U, Kim S
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685702
Parkinson's disease (PD) is a neurodegenerative disorder characterized by both motor symptoms and non-motor features. A hallmark of PD is the misfolding and accumulation of alpha-synuclein (α-syn), which triggers neuroinflammation...
6.
Sharma C, Kim S, Eo H, Kim S
Neural Regen Res
. 2024 Nov;
20(10):2855-2861.
PMID: 39610091
A critical unaddressed problem in Parkinson's disease is the lack of therapy that slows or hampers neurodegeneration. While medications effectively manage symptoms, they offer no long-term benefit because they fail...
7.
Lee G, Park S, Jung U, Kim S
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595073
Spinocerebellar ataxia (SCA) is a heterogeneous disorder characterized by impaired balance and coordination caused by cerebellar dysfunction. The absence of treatments approved by the U.S. Food and Drug Administration for...
8.
Kim S, Sharma C, Hong J, Kim J, Nam Y, Kim M, et al.
Stem Cell Res Ther
. 2024 Nov;
15(1):411.
PMID: 39521966
Background: Defects in the ataxin-2 (ATXN-2) protein and CAG trinucleotide repeat expansion in its coding gene, Atxn-2, cause the neurodegenerative disorder spinocerebellar ataxia type 2 (SCA2). While clinical studies suggest...
9.
Leem E, Kim S, Sharma C, Nam Y, Kim T, Shin M, et al.
Biomolecules
. 2024 Mar;
14(3).
PMID: 38540798
Although granule cell dispersion (GCD) in the hippocampus is known to be an important feature associated with epileptic seizures in temporal lobe epilepsy (TLE), the endogenous molecules that regulate GCD...
10.
Shin H, Choi S, Qu F, Yi M, Lee C, Kim S, et al.
Nanoscale
. 2023 Dec;
16(2):833-847.
PMID: 38093712
Astrocytes are highly activated following brain injuries, and their activation influences neuronal survival. Additionally, SOX9 expression is known to increase in reactive astrocytes. However, the role of SOX9 in activated...